×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CLDI – calidi biotherapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CLDI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
08:00 am
cldi
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
Low
Report
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
4/2
08:09 am
cldi
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 [Yahoo! Finance]
Medium
Report
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 [Yahoo! Finance]
4/2
08:00 am
cldi
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
Medium
Report
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
4/1
08:00 am
cldi
Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
Low
Report
Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
3/31
04:55 am
cldi
Research Suggests the Thymus is Critical in Immunotherapy Outcomes [TheStreet.com]
Low
Report
Research Suggests the Thymus is Critical in Immunotherapy Outcomes [TheStreet.com]
3/29
12:20 am
cldi
Major Discovery Could Reshape Cancer Immunotherapy [TheStreet.com]
High
Report
Major Discovery Could Reshape Cancer Immunotherapy [TheStreet.com]
3/28
09:25 pm
cldi
Calidi Biotherapeutics GAAP EPS of -$5.95 [Seeking Alpha]
High
Report
Calidi Biotherapeutics GAAP EPS of -$5.95 [Seeking Alpha]
3/27
04:25 pm
cldi
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
High
Report
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Operational Highlights
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/2
05:01 pm
cldi
Form 8-K Calidi Biotherapeutics, For: Mar 29
Medium
Report
Form 8-K Calidi Biotherapeutics, For: Mar 29
3/31
04:58 pm
cldi
Form SCHEDULE 13D Calidi Biotherapeutics, Filed by: Gavrilov Ognian Anguelov
Low
Report
Form SCHEDULE 13D Calidi Biotherapeutics, Filed by: Gavrilov Ognian Anguelov
3/27
05:01 pm
cldi
Form 10-K Calidi Biotherapeutics, For: Dec 31
High
Report
Form 10-K Calidi Biotherapeutics, For: Dec 31
3/27
04:58 pm
cldi
Form 8-K Calidi Biotherapeutics, For: Mar 27
High
Report
Form 8-K Calidi Biotherapeutics, For: Mar 27
3/11
05:09 pm
cldi
Form 8-K Calidi Biotherapeutics, For: Mar 05
Low
Report
Form 8-K Calidi Biotherapeutics, For: Mar 05
3/9
01:15 pm
cldi
Form SCHEDULE 13D Calidi Biotherapeutics, Filed by: Gavrilov Ognian Anguelov
Low
Report
Form SCHEDULE 13D Calidi Biotherapeutics, Filed by: Gavrilov Ognian Anguelov
3/9
06:02 am
cldi
Form 424B5 Calidi Biotherapeutics,
Low
Report
Form 424B5 Calidi Biotherapeutics,
3/6
06:01 am
cldi
Form 424B5 Calidi Biotherapeutics,
High
Report
Form 424B5 Calidi Biotherapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: